1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine has been researched along with dithionite in 1 studies
Studies (1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine) | Trials (1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine) | Studies (dithionite) | Trials (dithionite) | Recent Studies (post-2010) (dithionite) |
---|---|---|---|---|---|
11 | 0 | 5 | 1,120 | 0 | 102 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mills, JK; Needham, D | 1 |
1 other study(ies) available for 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine and dithionite
Article | Year |
---|---|
Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biophysics; Calorimetry; Calorimetry, Differential Scanning; Dithionite; Doxorubicin; Ions; Lipid Bilayers; Lipids; Liposomes; Mass Spectrometry; Membranes, Artificial; Models, Chemical; Permeability; Phosphatidylcholines; Spectrophotometry; Temperature; Time Factors | 2005 |